BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38162155)

  • 21. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
    Sánchez R; Ribera J; Morgades M; Ayala R; Onecha E; Ruiz-Heredia Y; Juárez-Rufián A; de Nicolás R; Sánchez-Pina J; Vives S; Zamora L; Mercadal S; Coll R; Cervera M; García O; Ribera JM; Martínez-López J
    Blood Cancer J; 2020 Apr; 10(4):43. PubMed ID: 32332702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.
    Olsson L; Lundin-Ström KB; Castor A; Behrendtz M; Biloglav A; Norén-Nyström U; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2018 Nov; 57(11):604-607. PubMed ID: 30203896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia.
    Noronha EP; Ferreira PMS; Andrade FG; Blunck CB; Camargo R; Gimba ERP; Pombo-de-Oliveira MS; Terra-Granado E;
    Hematol Transfus Cell Ther; 2023; 45(2):245-252. PubMed ID: 35995725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring
    Pastorczak A; Sedek L; Braun M; Madzio J; Sonsala A; Twardoch M; Fendler W; Nebral K; Taha J; Bielska M; Gorniak P; Romiszewska M; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Badowska W; Niedzwiecki M; Kazanowska B; Muszynska-Roslan K; Sobol-Milejska G; Karolczyk G; Koltan A; Ociepa T; Szczepanski T; Młynarski W
    Oncotarget; 2018 May; 9(40):25971-25982. PubMed ID: 29899835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
    Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
    Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.
    Chouvarine P; Antić Ž; Lentes J; Schröder C; Alten J; Brüggemann M; Carrillo-de Santa Pau E; Illig T; Laguna T; Schewe D; Stanulla M; Tang M; Zimmermann M; Schrappe M; Schlegelberger B; Cario G; Bergmann AK
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
    Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
    Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of IKZF1
    Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of
    Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
    Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
    Harvey RC; Mullighan CG; Wang X; Dobbin KK; Davidson GS; Bedrick EJ; Chen IM; Atlas SR; Kang H; Ar K; Wilson CS; Wharton W; Murphy M; Devidas M; Carroll AJ; Borowitz MJ; Bowman WP; Downing JR; Relling M; Yang J; Bhojwani D; Carroll WL; Camitta B; Reaman GH; Smith M; Hunger SP; Willman CL
    Blood; 2010 Dec; 116(23):4874-84. PubMed ID: 20699438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selected miRNA levels are associated with
    Krzanowski J; Madzio J; Pastorczak A; Tracz A; Braun M; Tabarkiewicz J; Pluta A; Młynarski W; Zawlik I
    Oncol Lett; 2017 Sep; 14(3):3853-3861. PubMed ID: 28927157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.
    Crepinsek K; Marinsek G; Kavcic M; Prelog T; Kitanovski L; Jazbec J; Debeljak M
    Radiol Oncol; 2021 Dec; 56(1):92-101. PubMed ID: 34957727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.
    Clappier E; Auclerc MF; Rapion J; Bakkus M; Caye A; Khemiri A; Giroux C; Hernandez L; Kabongo E; Savola S; Leblanc T; Yakouben K; Plat G; Costa V; Ferster A; Girard S; Fenneteau O; Cayuela JM; Sigaux F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Soulier J; Cavé H
    Leukemia; 2014 Jan; 28(1):70-7. PubMed ID: 24064621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood
    Brandes D; Yasin L; Nebral K; Ebler J; Schinnerl D; Picard D; Bergmann AK; Alam J; Köhrer S; Haas OA; Attarbaschi A; Marschall T; Stanulla M; Borkhardt A; Brozou T; Fischer U; Wagener R
    Hemasphere; 2023 Aug; 7(8):e925. PubMed ID: 37469802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
    Chen IM; Harvey RC; Mullighan CG; Gastier-Foster J; Wharton W; Kang H; Borowitz MJ; Camitta BM; Carroll AJ; Devidas M; Pullen DJ; Payne-Turner D; Tasian SK; Reshmi S; Cottrell CE; Reaman GH; Bowman WP; Carroll WL; Loh ML; Winick NJ; Hunger SP; Willman CL
    Blood; 2012 Apr; 119(15):3512-22. PubMed ID: 22368272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
    Buitenkamp TD; Pieters R; Gallimore NE; van der Veer A; Meijerink JP; Beverloo HB; Zimmermann M; de Haas V; Richards SM; Vora AJ; Mitchell CD; Russell LJ; Schwab C; Harrison CJ; Moorman AV; van den Heuvel-Eibrink MM; den Boer ML; Zwaan CM
    Leukemia; 2012 Oct; 26(10):2204-11. PubMed ID: 22441210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia.
    Palmi C; Savino AM; Silvestri D; Bronzini I; Cario G; Paganin M; Buldini B; Galbiati M; Muckenthaler MU; Bugarin C; Della Mina P; Nagel S; Barisone E; Casale F; Locatelli F; Lo Nigro L; Micalizzi C; Parasole R; Pession A; Putti MC; Santoro N; Testi AM; Ziino O; Kulozik AE; Zimmermann M; Schrappe M; Villa A; Gaipa G; Basso G; Biondi A; Valsecchi MG; Stanulla M; Conter V; Te Kronnie G; Cazzaniga G
    Oncotarget; 2016 Sep; 7(37):59260-59272. PubMed ID: 27449287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.